Edit |Yuer Lake
Produced by |Chaoqi.com Yu see the column
The "wind" of AI large models has already blown into all walks of life. The big health industry is also unwilling to be left behind, and has taken the express train of the times. Recently, ** reported that the A-share listed company Meinian Health added the "AIGC concept".
According to Flush data, the reason for its selection is that the company has been implementing AI applications since 2017, and at present, the company continues to use the combination of health examination big data and AI artificial intelligence to improve the accuracy of early disease screening, and has achieved core breakthroughs in AI-assisted phacophagus-assisted nail and breast nodule automatic identification and classification, AI-assisted chest CT reading, ultrasound process automation, and remote quality control of inspection products. Moreover, the company has also launched a number of AI innovative products and early screening technology products for common tumors.
With the blessing of artificial intelligence technology, Meinian Health, which was originally only a player in the traditional big health track, is also writing the main theme of its development with "high-quality growth". At the same time, in the process of development, Meinian has also been selected into many conventional concepts such as gene sequencing, margin trading, webcasting, blockchain, Healthy China, Shenzhen-Hong Kong Stock Connect, Alibaba concept, pension concept, Yangtze River Delta integration, MSCI concept, S&P Dow Jones A-shares, family doctors, dental care and so on.
It is understood that the Meinian Health Examination Center (hereinafter referred to as Meinian Health) behind Meinian Health is mainly engaged in health management services represented by health examinations. Recently, Guohai ** research report pointed out that Meinian Health launched the ** option incentive plan to create a new Meinian with cohesion.
In view of its sustained and steady growth, Guohai ** is optimistic about the value of the company's preventive medicine platform in the medium and long term, so it maintains the "**" rating. In addition, a number of brokerages have issued research reports, giving Meinian Health "recommended", "overweight", "better than the market" and "outperforming the industry" ratings, and is optimistic about the company's development in the long term.
It is observed that under the influence of multiple favorable factors such as the blessing of the concept of science and technology and the positive attitude of brokerage institutions, Meinian Health has also shown strong resilience and even explosiveness in the new era of people's increasing health awareness after the epidemic.
AI technology and big data are empowered in both directions, and Meinian Health accelerates its fast run
Compared with other waist brands, Meinian Health has the advantage of being deeply involved in the health examination track for many years and has a wealth of health big data of domestic residents.
As at the 2023 Annual Meeting of the Southern Finance and Economics International Forum and the Financial Golden Sail Award Ceremony hosted by the Southern Finance and Economics Group and hosted by the 21st Century Business Herald recently, Yu Rong, chairman of Meinian Health, pointed out in his speech: At present, innovative technology is advancing by leaps and bounds, and the four major scientific and technological changes represented by general technology represented by AI large models, biotechnology represented by gene technology, health management represented by wearable devices, and early screening and testing technology with new targets as the core have brought new opportunities for the development of the health industry.
In fact, the healthy development of Meinian has always been closely linked to the development of science and technology. Through the professional, standardized and large-scale operation of the national physical examination center, Meinian is at the forefront of the industry in terms of digitalization. At the same time, through medical service model and product innovation, Meinian Health is also determined to become a digital platform for the whole life cycle health management of users.
As we all know, health examination is the first stop of user health management, which can not only obtain a large number of sub-health users and become a super traffic entrance, but also provide a series of value-added services such as post-examination specialty, genetic testing, and chronic disease management around the whole process of physical examination before, during and after the examination, forming a relatively complete user life cycle management and commercial closed loop.
It is understood that Meinian Health has more than 600 physical examination centers, providing professional health examination services for about 30 million people every year, generating massive health big data covering social demographics, health history, lifestyle, physical examination, laboratory examination, imaging examination, etc., and has become the largest personal health data center in China.
When the era of AI large models comes, Meinian Health has also applied the advantages of its health examination big data to related technologies and services, which has greatly improved efficiency.
For example, with the use of IT technology, Meinian Health has realized the automation of ultrasound processes and remote quality control of inspection items. With the assistance of AI, Meinian Health has also realized the automatic identification and classification of nail and breast nodules and the automatic reading of chest CT films. At the same time, the report robot with "integrated" AI technology can automatically conduct a preliminary review of the user's physical examination report.
At the same time, in the health check-up scenario, with the gradual strengthening of the penetration of AI, Meinian Health has also continuously launched innovative physical examination products. For example, Meinian Health's innovative product focusing on early screening of stroke and Alzheimer's disease, "Brain Ruijia", is the first in the country.
Through the application of imaging AI analysis technology and the whole brain standard database of all ages in healthy people in China, structural abnormalities and functional degeneration in the early stage of brain disease can be identified and identified.
In addition, with the advent of the era of AI large models, Meinian Health's big data advantages also provide a strong guarantee for the quantity, quality, and diversity of its robot pre-training data, and are also the key factors for the performance of Meinian Health's AI large model application capabilities.
Large-scale model application empowerment, Meinian Health interprets technology as the primary productive force
As mentioned above, the wave of AI large models is rushing to the big health industry. And Meinian Health is also actively embracing. It is understood that Meinian Health is transforming the physical examination industry based on generative AI technology and the current hot AI model.
At present, including AI intelligent main examination, AI marketing assistant, AI doctor assistant, AI health management assistant, health Xiaomei, digital health person, AI physical examination report interpretation, AI mental health products, AI health insurance products, etc., have all been productized, which has also formed a cost reduction and efficiency increase effect within Meinian, and for serving customers, it has improved the efficiency and experience of customer health examination.
It is understood that from the beginning of its establishment, Meinian Health has attached great importance to the construction and improvement of the industrial ecology of the industry, and has gradually formed a development tone driven by "innovation + technology", and at the same time, with the help of advanced technology, it has continuously launched a full range of "specialized, refined, special and new" innovative products covering "inspection, medical care, insurance and management", and gradually covered the whole life cycle of user health management.
Regarding the scientific and technological route chosen by Meinian Health, Xu Tao, President of Meinian Health Group, made a speech at the 2023 (Chengdu) "Specialized, Specialized and New" Entrepreneur Forum in mid-September, which can be described as hitting the nail on the head. According to Meinian Health Group***, at that time, Xu Tao shared several wonderful views.
The first is the development opportunities brought by the four major technologies such as AI large model, gene technology, wearable devices, and early screening test with new targets as the core for the big health industry, and the second is that digitalization was a concept, innovation, and trend in the past, but now it is the standard configuration of enterprises, technical facilities, and even the key to determining the life and death of enterprises.
The third is to build medical health through AIGC and implement related application scenarios, which has huge potential value both internally and externally. Fourth, with the support of big data on the platform and these technologies and applications, Meinian Health is just in line with the general trend of closed-loop health management throughout the life cycle of customers, which can be described as taking advantage of the trend and becoming a matter of course.
Therefore, it can be said that the healthy development process of Meinian is enough to perfectly interpret that science and technology are the primary productive forces.
The volume and price have risen together, and the future of Meinian Health is promising
No matter how beautiful the concept is, it must be implemented at the level of company performance after all. What is commendable is that because the performance of Meinian Health depends on the line inspection center, it is inevitably affected by the epidemic in the past few years. As a result, there has been a staged loss situation in recent years.
However, according to the third quarter financial report data of Meinian Health, in the first three quarters of this year, Meinian Health achieved revenue of 721.7 billion yuan, a year-on-year increase of 2481%；Net profit attributable to shareholders of the listed company was 22.6 billion yuan, a year-on-year increase of 1581% to turn losses into profits. As of the end of the reporting period, there were 597 health flag inspection centers in Meinian.
As for the reasons for the growth of performance, Meinian Health said that the overall business environment is improving, and the volume and price of health examination services are rising significantly. In addition, the company continues to promote high-quality products and services, so it has also achieved a two-way increase in customer flow and unit price.
It is observed that Meinian Health's performance has grown steadily and the volume and price have risen together, thanks to the fact that it follows the logic of a positive cycle of performance in many aspects.
First of all, in terms of traffic. As China's Internet growth market is coming to an end, the retention of old customers is also particularly important. Meinian Health has also paid attention to the operation of private domain traffic, the activation of existing users, and the repurchase of products and services.
At the same time, in terms of attracting new users, Meinian Health has also continued to expand the local life channels of Meituan and Douyin to maintain the growth of new users, and has formed a commercial closed loop of public domain drainage, private domain traffic precipitation and conversion and realization. Moreover, in terms of group orders, Meinian Health is replicating the "Langfang model" across the country, carrying out public domain volume and private domain transformation, so that traffic can truly become value.
Secondly, Meinian Health's advantage lies in its standardized products and services. Therefore, through this kind of service, the operation of the B-end government and enterprise large customer system can also create a larger revenue volume for the company. Therefore, it was able to make efforts at the B and C ends at the same time and continuously expand the scale of revenue.
Thirdly, in addition to standardized physical examinations**, the product diversification of Meinian Health is also deepening and bringing positive feedback. For example, Meinian Health has launched a special product series of "Meinian Special Inspection Health Box", including capsule gastroscope boxes, gene boxes and other products to improve the detection and utilization of non-bottleneck departments, which can further increase product repurchase and more differentiated income, and enhance the competitiveness of the industry.
It can be seen that under the calm layout of brand, traffic, products and other aspects, Meinian Health is steadily seeking growth. Its commercial buildings are also becoming more and more stable, and the industry moat is also deepening, and the future is promising.
Conclusion
The data shows that with the continuous improvement of the physical and mental health awareness of Chinese residents, the market scale of the health examination industry is also expanding. Statistics show that the market size of China's physical examination industry will be close to 200 billion yuan in 2022, with a compound growth rate of 13% from 2015 to 2021.
With the two-way blessing of industry big data and AI technology, Meinian Health, as the vanguard of the health examination industry, is undoubtedly standing at the forefront of the times. It is foreseeable that in the increasingly technological health track, the future of Meinian Health will be promising.